Bandhan Nifty Alpha 50 Index Fund - Direct Plan

Our Funds / ETF/Index Funds

Bandhan Nifty Alpha 50 Index Fund - Direct Plan

The investment objective of the Scheme is to replicate the Nifty Alpha 50 Index by investing in securities of the Nifty Alpha 50 Index in the same proportion / weightage with an aim to provide returns before expenses that tracks the total return of Nifty Alpha 50 Index, subject to tracking errors.

However, there is no assurance or guarantee that the objectives of the scheme will be realized and the scheme does not assure or guarantee any returns.

ETF/IndexInception Date:09/11/2023
Ask an Advisor

The fund aims to replicate the Nifty Alpha 50 Index by investing in the underlying securities in the same proportion, subject to tracking error. 

The index invests in stocks that have generated high alpha over the last year and is designed to be nimble so it can leverage compelling investment opportunities.

  • Min Investment 1,000
  • Min SIP Amount 100
  • Exit Load

    Nil

Select

This scheme has not completed one year.

NAV 12.6419 as on 04/03/20241 Day Change: 0.07(0.55%)

Tier 1 Benchmark : Nifty Alpha 50 IndexAlternate Benchmark : Nifty 50 TRI

This is a new scheme and required performance data is not yet available.

This fund is managed by Mr. Nemish Sheth (w.e.f 09/11/2023)

View fund performance of other funds managed by Mr. Nemish Sheth

Past performance may or may not be sustained in future.
Regular and Direct Plans have different expense structure. Direct Plan shall have a lower expense ratio excluding distribution expenses, commission expenses etc.

Taxation:

For taxation, please refer the link :  https://bit.ly/3spfzbo

Bandhan Nifty Alpha 50 Index Fund

(Scheme Risk-o-meter)

Investors understand that their principal will be at Very High Risk.

Nifty Alpha 50 Index

(Tier 1 Benchmark Risk-o-meter)

This product is suitable for investors who are seeking*:
• To create wealth over long term
• Investment in equity and equity related instruments belonging to Nifty Alpha 50 Index

*Investors should consult their financial advisers if in doubt about whether the product is suitable for them.